Clopidogrel diminishes hemodialysis access graft thrombosis

Nephron - Clinical Practice

Volumn 102, Issue 3-4, 2006, Pages

  Trimarchi, Hernán ^a   Young, Pablo ^a   Forrester, Mariano ^a   Schropp, Juan ^a   Pereyra, Horacio ^a   Freixas, Emilio ^a  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

Author keywords

Atherosclerosis; Clopidogrel; Fistula; Graft; Hemodialysis; Thrombosis; Vascular access

Indexed keywords

ANTICOAGULANT AGENT; CLOPIDOGREL;

AGED; ARTICLE; BLEEDING; BLOOD VESSEL GRAFT; BRAIN HEMORRHAGE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GRAFT PATENCY; GYNECOLOGIC DISEASE; HEMATOCRIT; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT HEMORRHAGE; RETROPERITONEAL HEMORRHAGE; SKIN REDNESS; SURVIVAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOSIS; THROMBOSIS PREVENTION; VASCULAR ACCESS;

AGED; CATHETERS, INDWELLING; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POLYTETRAFLUOROETHYLENE; PROSPECTIVE STUDIES; RENAL DIALYSIS; THROMBOSIS; TICLOPIDINE;

EID: 33344470885     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089671     Document Type: Article

References (19)

1. Windus DW: Permanent vascular access: a nephrologist's view. Am J Kidney Dis 1993;21: 457-471.
2. Feldman HI, Kobrin S, Wasserstein A: Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996;7:523-535.
3. Feldman HI, Held PJ, Hutchinson JT, et al: Hemodialysis vascular access morbidity in the United States. Kidney Int 1993;43:1091-1096.
4. Schwab SJ: Vascular access for hemodialysis. Kidney Int 1999;55:2078-2090.
5. Fan PY, Schwab SJ: Vascular access. Concepts for the 1990s. J Am Soc Nephrol 1992;3:1-11.
6. Domoto DT, Bauman JE, Joist JH: Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Thromb Res 1991;62:737-743.
7. Sreedhara R, Himmelfarb J, Lazarus M, Hakim R: Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Kidney Int 1994;45:1477-1483.
8. Kaufman JS, O'Connor TZ, Zhang JH, Cronin RE: Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol 2003;14: 2313-2321.
9. Best JM, Lennon R, Ting HH, et al: The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. Am J Cardiol 2002;39:1113-1119.
10. US Renal Data System: USRDS 1999 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1999.
11. Goldsmith DJA, Covic A: Coronary artery disease in uremia: etiology, diagnosis, and therapy. Kidney Int 2001;60:2059-2078.
12. Braun WE, Phillips DF, Vidt DG: Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 1984;16:603-607.
13. CAPRIE Steering Committee: A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
14. Deray G, Bagnis C, Brouard R, et al: Clopidogrel activities in patients with renal function impairment. Clin Drug Invest 1998;4:319-328.
15. Boneau B, Destelle G, on behalf of the Study Group: Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients. Thromb Haemost 1996;76:939-943.
16. Kaufman JS, Fiore L, Hasbargen JA, O'Connor T, Perdriset G: A pharmacodynamic study of clopidogrel in chronic hemodialysis patients. J Thromb Thrombolysis 2000;10:127-131.
17. Galbraith S, Fan P, Collins D, et al: Hemodialysis fistula thromboses: a prospective evaluation of anatomic versus non-anatomic causes (abstract). J Am Soc Nephrol 1992;3:365.
18. Young EW, Dykstra DM, Goodkin DA, et al: Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2002; 61:2266-2271.
19. Munda R, First MR, Alexander JW, et al: Polytetrafluoroethylene graft survival in hemodialysis. JAMA 1983;249:219-222.